Galmed Pharmaceuticals Ltd. (GLMD)
NASDAQ: GLMD · Real-Time Price · USD
1.570
-0.050 (-3.09%)
Apr 25, 2025, 4:00 PM EDT - Market closed

Galmed Pharmaceuticals Market Cap

Galmed Pharmaceuticals has a market cap or net worth of $3.55 million as of April 25, 2025. Its market cap has increased by 77.26% in one year.

Market Cap
3.55M
Enterprise Value
-11.79M
1-Year Change
77.26%
Ranking
Category
Stock Price
$1.57

Market Cap Chart

Since March 13, 2014, Galmed Pharmaceuticals's market cap has decreased from $145.70M to $3.55M, a decrease of -97.57%. That is a compound annual growth rate of -28.39%.

History

DateMarket Cap% Change
Apr 25, 20252.60M-45.83%
Dec 31, 20244.80M166.67%
Dec 29, 20231.80M-85.71%
Dec 30, 202212.60M-72.43%
Dec 31, 202145.70M-30.44%
Dec 31, 202065.70M-45.93%
Dec 31, 2019121.50M23.23%
Dec 31, 201898.60M-11.33%
Dec 29, 2017111.20M185.13%
Dec 30, 201639.00M-53.85%
Dec 31, 201584.50M42.98%
Dec 31, 201459.10M-59.44%
View and export this data all the way back to 2014. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 794.31B
UnitedHealth Group 381.06B
Johnson & Johnson 371.93B
AbbVie 329.14B
Novo Nordisk 272.76B
Abbott Laboratories 223.47B
AstraZeneca 214.65B
Novartis AG 211.71B
Market Cap Rankings